Evidence map›Paper›PMID 41408283›Full record

ArticleMalaria journal2025

Three-year trends in malaria transmission parameters under deployment of Interceptor®G1, Interceptor®G2 and PermaNet®3.0 insecticide-treated bed nets in South-Western Burkina Faso.

Madou Tapsoba, Wamdaogo Moussa Guelbeogo, Antoine Sanou, Soumanaba Zongo, Christelle Gogue, Siaka Debe, Kyra Arnett, Kelly Davis, Jenny Shannon, Peder Digre and 11 more

Abstract read
In one paragraph

Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Impact of Insecticide-Treated Nets onTropical medicine and infectious disease · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Madou TapsobaCentre national de recherche et de formation Sur le paludisme, Ouagadougou, Burkina Faso.
Wamdaogo Moussa GuelbeogoCentre national de recherche et de formation Sur le paludisme, Ouagadougou, Burkina Faso. guelbcnrfp@yahoo.fr.
Antoine SanouCentre national de recherche et de formation Sur le paludisme, Ouagadougou, Burkina Faso.
Soumanaba ZongoCentre national de recherche et de formation Sur le paludisme, Ouagadougou, Burkina Faso.
Christelle GoguePATH, Washington, DC, USA.
Siaka DebeCentre national de recherche et de formation Sur le paludisme, Ouagadougou, Burkina Faso.
Kyra ArnettPATH, Washington, DC, USA.
Kelly DavisPATH, Washington, DC, USA.
Jenny ShannonPATH, Washington, DC, USA.
Peder DigrePATH, Washington, DC, USA.
Julia MwesigwaPATH, Washington, DC, USA.
Kenzie TynuvPATH, Washington, DC, USA.
Christen FornadelInnovative Vector Control Consortium, IVCC, Liverpool, UK.
Sagnon N'FaléCentre national de recherche et de formation Sur le paludisme, Ouagadougou, Burkina Faso.
Molly RobertsonGlobal Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.
Joseph D ChallengerMedical Research Council (MRC) Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
Gauthier TougriCentre national de recherche et de formation Sur le paludisme, Ouagadougou, Burkina Faso.
Adama GansanéCentre national de recherche et de formation Sur le paludisme, Ouagadougou, Burkina Faso.
Hilary RansonVector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Gnankiné OlivierUniversité Joseph KI-ZERBO, Ouagadougou, Burkina Faso.
Joseph WagmanPATH, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn South-Western Burkina Faso, where malaria remains highly endemic, the widespread resistance of Anopheles mosquitoes to pyrethroid is reducing the effectiveness of insecticide-treated nets (ITNs). This study assessed 3-year trends in key entomological indicators following the deployment of standard pyrethroid-only (Interceptor®G1), dual-AI pyrethroid-chlorfenapyr (Interceptor®G2) and pyrethroid-PBO (PermaNet®3.0).

methodsA longitudinal entomological study was conducted from August 2019 to February 2022 in three malaria-endemic health districts, each receiving a different ITN type. Weekly mosquito sampling was conduct in three villages per district using Human Landing Catches at two households and CDC light traps at six households. Mosquitoes were morphologically and molecularly identified, and Plasmodium falciparum infection was detected by PCR. Key indicators included mosquito density, biting behaviour, sporozoite infection rate (SIR), and entomological inoculation rate (EIR).

resultsA total of 73,101 female Anopheles mosquitoes were collected. The dominant vector species was An. gambiae s.l. (> 59%), with An. coluzzii prevalent in Banfora (65.5%) and An. gambiae s.s. in Gaoua (91%) and Orodara (83.3%). In Banfora, where Pyr-CFR Interceptor G2 nets were deployed, Anopheles density declined by 88.7% over the 3 years. In Gaoua (Pyr-only ITNs), mosquito density declined initially but rebounded in year 3. In Orodara (Pyr-PBO ITNs), densities remained relatively stable. Trends in SIR and EIR mirrored those in vector density, with decline in year 2 followed by resurgences in Banfora and Gaoua during year 3.

conclusionDual-AI nets, particularly Pyr-CFR Interceptor®G2, were associated with sustained reductions in mosquito density and transmission indicators over 2 years. However, resurgence of entomological indices by the third year highlights the need for improved ITN durability and complementary vector control strategies. Continuous entomological surveillance and integrated, locally adapted interventions remain essential for sustaining malaria control in areas with high insecticide resistance.

Indexed as

AnophelesInsecticidesInsecticide-Treated BednetsMalariaMalaria, FalciparumMosquito ControlMosquito VectorsPyrethrinsAnimalsBurkina FasoFemaleHumansInsecticide ResistanceLongitudinal StudiesPlasmodium falciparumchlorfenapyrInsecticidesPyrethrinsChlorfenapyrDual-active ingredient netsMalaria transmissionPiperonyl butoxide (PBO)Vector control

Identifiers

PMID41408283
PMCPMC12821909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.